Stolfi, Carmine <br/><br/>
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase.  [electronic resource] 

 -  Carcinogenesis  Jun 2008 
 - 1258-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2180 
<br/><br/><label>Standard No.: </label>10.1093/carcin/bgn122  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Blotting, Western<br/>Cell Proliferation--drug effects<br/>Colonic Neoplasms--metabolism<br/>Gene Expression--drug effects<br/>Humans<br/>Immunoprecipitation<br/>Mesalamine--pharmacology<br/>Mice<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>S Phase--drug effects<br/>cdc25 Phosphatases--biosynthesis